Bora Pharmaceuticals Co., Ltd./ADR

Bora Pharmaceuticals Co., Ltd./ADR

Bora Pharmaceuticals was founded in 1995 and is based in Taiwan. The company's ADR (American Depositary Receipt) trades over-the-counter, giving international investors exposure to its operations. Wealth origin traces to the company's founding and growth within the pharmaceutical industry, though no specific founding family or principal is named in public records. The company's strategy centers on contract manufacturing and development services for pharmaceutical clients. It focuses on oral solid dosage forms, including tablets and capsules, and provides services ranging from formulation development to commercial production. Bora serves generic drug makers and specialty pharmaceutical companies across Asia, North America, and Europe. Its manufacturing facilities are located in Taiwan and China. Bora Pharmaceuticals has multiple subsidiaries, including Bora Pharmaceutical Services and Bora Laboratories. The company does not disclose total professionals or AUM as a pharmaceutical firm rather than an investment vehicle. It has no known philanthropic structures or asset management arms. The structural differentiator is its hybrid role as a listed pharmaceutical manufacturer and CDMO, which provides operational cash flows distinct from a family office or asset manager. The ADR structure allows US investors to trade shares without direct exposure to Taiwan's local exchange.